Diabetic Nephropathy: Pathogenesis and Management

AUTHORS

Zohreh Rahimi 1 , *

1 Medical Biology Research Center, Dept. of Clinical Biochemistry, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran

How to Cite: Rahimi Z. Diabetic Nephropathy: Pathogenesis and Management, J Kermanshah Univ Med Sci. 2016 ; 20(3):e69669. doi: 10.22110/jkums.v20i3.3323.

ARTICLE INFORMATION

Journal of Kermanshah University of Medical Sciences: 20 (3); e69669
Published Online: December 19, 2016
Article Type: Review Article
Received: August 30, 2016
Accepted: September 27, 2016
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Diabetic nephropathy (DN) is a major microvascular complication of diabetes mellitus and is the leading cause of end-stage renal disease (ESRD). Genetic, metabolic, systemic, and renal hemodynamic factors are involved in the pathogenesis of DN. Advanced glycation end products (AGEs), hypertension, oxidative stress, inflammation, and genetic susceptibility are risk factors for susceptibility to DN and its development. Management approaches of DN are based on the inhibitors of some components of the renin angiotensin aldosterone system (RAAS), AGEs, and protein kinase C (PKC) and combined antioxidants therapy with anti-inflammatory agents. The present review looks at some mechanisms involved in DN and its progression and also management approaches according to the inhibition of the risk factors of the disease.

Keywords

Diabetic

© 2016, Journal of Kermanshah University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Fulltext

References

  • 1.

    The references of this article is available on PDF

  • COMMENTS

    LEAVE A COMMENT HERE: